These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29649262)

  • 21. Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis.
    Ustündağ-Okur N; Gökçe EH; Bozbıyık Dİ; Eğrilmez S; Ozer O; Ertan G
    Eur J Pharm Sci; 2014 Oct; 63():204-15. PubMed ID: 25111119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of the antimicrobial peptide nisin Z with conventional antibiotics and the use of nanostructured lipid carriers to enhance antimicrobial activity.
    Lewies A; Wentzel JF; Jordaan A; Bezuidenhout C; Du Plessis LH
    Int J Pharm; 2017 Jun; 526(1-2):244-253. PubMed ID: 28461263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
    Chen CC; Tsai TH; Huang ZR; Fang JY
    Eur J Pharm Biopharm; 2010 Mar; 74(3):474-82. PubMed ID: 20060469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minocycline encapsulated chitosan nanoparticles for central antinociceptive activity.
    Nagpal K; Singh SK; Mishra DN
    Int J Biol Macromol; 2015 Jan; 72():131-5. PubMed ID: 25111492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution.
    Bondì ML; Craparo EF; Giammona G; Drago F
    Nanomedicine (Lond); 2010 Jan; 5(1):25-32. PubMed ID: 20025461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chitosan-tailored lipidic nanoconstructs of Fusidic acid as promising vehicle for wound infections: An explorative study.
    Thakur K; Sharma G; Singh B; Chhibber S; Patil AB; Katare OP
    Int J Biol Macromol; 2018 Aug; 115():1012-1025. PubMed ID: 29680503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and in vivo evaluation of an innovative "Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles" formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics.
    Cirri M; Mennini N; Maestrelli F; Mura P; Ghelardini C; Di Cesare Mannelli L
    Int J Pharm; 2017 Apr; 521(1-2):73-83. PubMed ID: 28229944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment.
    Shazly GA
    Biomed Res Int; 2017; 2017():2120734. PubMed ID: 28194408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel gel based on an ionic complex from a dendronized polymer and ciprofloxacin: Evaluation of its use for controlled topical drug release.
    García MC; Cuggino JC; Rosset CI; Páez PL; Strumia MC; Manzo RH; Alovero FL; Alvarez Igarzabal CI; Jimenez-Kairuz AF
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():236-46. PubMed ID: 27612709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid lipid nanoparticles for sustained pulmonary delivery of Yuxingcao essential oil: Preparation, characterization and in vivo evaluation.
    Zhao Y; Chang YX; Hu X; Liu CY; Quan LH; Liao YH
    Int J Pharm; 2017 Jan; 516(1-2):364-371. PubMed ID: 27884712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bio-fabrication and statistical optimization of polysorbate 80 coated chitosan nanoparticles of tapentadol hydrochloride for central antinociceptive effect: in vitro-in vivo studies.
    Patil GB; Surana SJ
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):505-514. PubMed ID: 27017892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide.
    Gonçalves LM; Maestrelli F; Di Cesare Mannelli L; Ghelardini C; Almeida AJ; Mura P
    Eur J Pharm Biopharm; 2016 May; 102():41-50. PubMed ID: 26925503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of ciprofloxacin complex loaded PLGA nanoparticles for pulmonary treatment of cystic fibrosis infections: Design of experiments approach.
    Günday Türeli N; Türeli AE; Schneider M
    Int J Pharm; 2016 Dec; 515(1-2):343-351. PubMed ID: 27744035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction and in vitro/in vivo evaluation of 17-allylamino-17-demethoxygeldanamycin (17AAG)-loaded PEGylated nanostructured lipid carriers.
    Wang Z; Wang J; Yang S; Hou S
    Drug Dev Ind Pharm; 2016 Jan; 42(1):91-98. PubMed ID: 25853294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation of andrographolide-loaded solid lipid nanoparticles and their in vitro and in vivo evaluations: characteristics, release, absorption, transports, pharmacokinetics, and antihyperlipidemic activity.
    Yang T; Sheng HH; Feng NP; Wei H; Wang ZT; Wang CH
    J Pharm Sci; 2013 Dec; 102(12):4414-25. PubMed ID: 24166599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.